Literature DB >> 15298579

Assessing Cost-Effectiveness--Mental Health: introduction to the study and methods.

Michelle M Haby1, Rob Carter, Cathrine Mihalopoulos, Anne Magnus, Kristy Sanderson, Gavin Andrews, Theo Vos.   

Abstract

OBJECTIVE: The Assessing Cost-Effectiveness - Mental Health (ACE-MH) study aims to assess from a health sector perspective, whether there are options for change that could improve the effectiveness and efficiency of Australia's current mental health services by directing available resources toward "best practice" cost-effective services.
METHOD: The use of standardized evaluation methods addresses the reservations expressed by many economists about the simplistic use of League Tables based on economic studies confounded by differences in methods, context and setting. The cost-effectiveness ratio for each intervention is calculated using economic and epidemiological data. This includes systematic reviews and randomised controlled trials for efficacy, the Australian Surveys of Mental Health and Wellbeing for current practice and a combination of trials and longitudinal studies for adherence. The cost-effectiveness ratios are presented as cost (A$) per disability-adjusted life year (DALY) saved with a 95% uncertainty interval based on Monte Carlo simulation modelling. An assessment of interventions on "second filter" criteria ("equity", "strength of evidence", "feasibility" and "acceptability to stakeholders") allows broader concepts of 'benefit' to be taken into account, as well as factors that might influence policy judgements in addition to cost-effectiveness ratios.
CONCLUSIONS: The main limitation of the study is in the translation of the effect size from trials into a change in the DALY disability weight, which required the use of newly developed methods. While comparisons within disorders are valid, comparisons across disorders should be made with caution. A series of articles is planned to present the results.

Mesh:

Year:  2004        PMID: 15298579     DOI: 10.1080/j.1440-1614.2004.01420.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  10 in total

1.  Increasing Access to Cognitive-Behavioural Therapy (CBT) for the Treatment of Mental Illness in Canada: A Research Framework and Call for Action.

Authors:  Krista A Payne; Gail Myhr
Journal:  Healthc Policy       Date:  2010-02

2.  Cost-effectiveness of pharmacological and psychosocial interventions for schizophrenia.

Authors:  Pudtan Phanthunane; Theo Vos; Harvey Whiteford; Melanie Bertram
Journal:  Cost Eff Resour Alloc       Date:  2011-05-13

Review 3.  [Care requirements for severe mental disorders. Scientific evidence for integration of clinical psychiatry and community psychiatry].

Authors:  S Weinmann; W Gaebel
Journal:  Nervenarzt       Date:  2005-07       Impact factor: 1.214

4.  A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots.

Authors:  Elahe Khorasani; Majid Davari; Abbas Kebriaeezadeh; Farshad Fatemi; Ali Akbari Sari; Vida Varahrami
Journal:  Eur J Health Econ       Date:  2022-03-02

5.  Is early intervention in psychosis cost-effective over the long term?

Authors:  Cathrine Mihalopoulos; Meredith Harris; Lisa Henry; Susy Harrigan; Patrick McGorry
Journal:  Schizophr Bull       Date:  2009-06-09       Impact factor: 9.306

6.  Schizophrenia in Thailand: prevalence and burden of disease.

Authors:  Pudtan Phanthunane; Theo Vos; Harvey Whiteford; Melanie Bertram; Pichet Udomratn
Journal:  Popul Health Metr       Date:  2010-08-17

7.  A population-based model for priority setting across the care continuum and across modalities.

Authors:  Leonie Segal; Duncan Mortimer
Journal:  Cost Eff Resour Alloc       Date:  2006-03-28

8.  A survey of the clinical acceptability of screening for postnatal depression in depressed and non-depressed women.

Authors:  Alan W Gemmill; Bronwyn Leigh; Jennifer Ericksen; Jeannette Milgrom
Journal:  BMC Public Health       Date:  2006-08-17       Impact factor: 3.295

9.  Assessing cost-effectiveness in obesity (ACE-obesity): an overview of the ACE approach, economic methods and cost results.

Authors:  Rob Carter; Marj Moodie; Alison Markwick; Anne Magnus; Theo Vos; Boyd Swinburn; Michele M Haby
Journal:  BMC Public Health       Date:  2009-11-18       Impact factor: 3.295

10.  Helping to prioritise interventions for depression and schizophrenia: use of Population Impact Measures.

Authors:  Richard F Heller; Islay Gemmell; Lesley Patterson
Journal:  Clin Pract Epidemiol Ment Health       Date:  2006-03-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.